Literature DB >> 22431873

Congenital cholesteatoma: predictors for residual disease and hearing outcomes.

Amanda L Stapleton1, Ann Marie Egloff, Robert F Yellon.   

Abstract

OBJECTIVE: To determine predictive factors for residual disease and hearing outcomes of surgery for congenital cholesteatoma (CC).
DESIGN: Retrospective record review of surgery for CC from January 1, 1998, through December 31, 2010. The initial extent of CC was staged using the system as defined by Potsic et al.
SETTING: Tertiary care children's hospital. PATIENTS: Eighty-one children (82 ears) underwent a total of 230 operations for CC. The mean (SD) age was 5.3 (2.9) years, and the mean follow-up was 4.3 years. INTERVENTION: Initial and subsequent operations for CC and audiologic evaluations. MAIN OUTCOME MEASURES: Statistical analyses were performed to determine factors associated with increased residual disease for CC and poorer hearing outcomes.
RESULTS: Higher initial stage of disease, erosion of ossicles, and removal of ossicles were significantly associated with increased likelihood of residual CC (46%, 50%, and 51%, respectively; P < .001). More extensive disease at initial surgery was associated with poorer final hearing outcomes (P < .05). Other significant findings included CC medial to the malleus (41.5%) or incus (54.3%), abutting the incus (51.3%) or stapes (63%), or enveloping the stapes (50%); all patients had increased residual disease (all P < .05). Excellent audiometric results (air-bone gap of ≤20 decibel hearing level) were obtained in 63 (77%) of the 82 ears.
CONCLUSIONS: More extensive initial disease, ossicular erosion, and the need for ossicular removal were associated with residual disease. On the basis of our data, the best chance for completely removing CC at initial surgery involves removing involved ossicles if they are eroded, if the CC is abutting or enveloping the incus or stapes, if the CC is medial to the malleus or incus, or if the matrix of the CC is violated. These results may help guide surgeons to achieve the best results for their patients.

Entities:  

Mesh:

Year:  2012        PMID: 22431873     DOI: 10.1001/archoto.2011.1422

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

1.  Clinical Characteristics and Treatment Outcomes of Congenital Cholesteatoma.

Authors:  In Sik Song; Won Gue Han; Kang Hyeon Lim; Kuk Jin Nam; Myung Hoon Yoo; Yoon Chan Rah; June Choi
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

2.  Non-echoplanar diffusion-weighted MRI in children and adolescents with cholesteatoma: reliability and pitfalls in comparison to middle ear surgery.

Authors:  Thekla von Kalle; Peter Amrhein; Assen Koitschev
Journal:  Pediatr Radiol       Date:  2015-02-13

3.  Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis.

Authors:  Nelson Gilberto; Sara Custódio; Tiago Colaço; Ricardo Santos; Pedro Sousa; Pedro Escada
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-18       Impact factor: 2.503

Review 4.  Diseases of the middle ear in childhood.

Authors:  Amir Minovi; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

5.  Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma.

Authors:  Joo Hyun Park; Jungmin Ahn; Il Joon Moon
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-06-27       Impact factor: 3.372

6.  Clinical Aspects and Surgical Outcomes of Congenital Cholesteatoma in 93 Children: Increasing Trends of Congenital Cholesteatoma from 1997 through 2012.

Authors:  Hyun Soo Cho; Hak Geon Kim; Da Jung Jung; Jeong Hun Jang; Sang Heun Lee; Kyu-Yup Lee
Journal:  J Audiol Otol       Date:  2016-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.